Ditchcarbon
  • Customers
  1. Organizations
  2. Eurofarma
Public Profile
Pharmaceutical Preparation Manufacturing
BR
updated 8 days ago

Eurofarma

Company website

Eurofarma, officially known as Eurofarma Laboratórios S.A., is a prominent Brazilian pharmaceutical company headquartered in São Paulo, Brazil. Established in 1972, Eurofarma has grown to become a key player in the Latin American pharmaceutical industry, with a strong presence across various operational regions, including Central and South America. Specialising in the development, manufacturing, and marketing of prescription medicines, generics, and over-the-counter products, Eurofarma is recognised for its commitment to quality and innovation. The company’s diverse portfolio includes therapeutic areas such as oncology, cardiology, and central nervous system disorders, setting it apart with its focus on patient-centric solutions. With a robust market position, Eurofarma has achieved significant milestones, including numerous certifications and awards for excellence in pharmaceutical practices, reinforcing its reputation as a trusted name in healthcare.

DitchCarbon Score

How does Eurofarma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

51

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Eurofarma's score of 51 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

72%

Let us know if this data was useful to you

Eurofarma's reported carbon emissions

In 2024, Eurofarma reported total carbon emissions of approximately 50,093,000 kg CO2e. This includes Scope 1 emissions of about 21,450,000 kg CO2e, primarily from stationary combustion (approximately 13,723,000 kg CO2e) and mobile combustion (about 2,708,000 kg CO2e). Scope 2 emissions were around 4,340,000 kg CO2e, while Scope 3 emissions totalled approximately 24,303,000 kg CO2e, with significant contributions from business travel (about 3,377,000 kg CO2e) and upstream transportation and distribution (approximately 7,523,000 kg CO2e). In 2023, Eurofarma's total emissions were approximately 41,604,000 kg CO2e, showing a notable increase from the previous year. The breakdown included Scope 1 emissions of about 16,992,000 kg CO2e, Scope 2 emissions of approximately 7,827,000 kg CO2e, and Scope 3 emissions of around 16,785,000 kg CO2e. The company has not publicly committed to specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. However, Eurofarma continues to disclose its emissions data transparently, reflecting its commitment to sustainability and climate accountability. The emissions data is sourced directly from Eurofarma Laboratórios S.A., with no cascading from a parent organisation.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
12,594,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
4,611,000
0,000,000
00,000,000
0,000,000
0,000,000
0,000,000
Scope 3
6,146,000
0,000,000
0,000,000
0,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Eurofarma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Eurofarma is in BR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Eurofarma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Adium Pharma S.A.

UY
•
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 14 days ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Blink Charging Co.

US
•
Sale, maintenance, repair of motor vehicles, motor vehicles parts, motorcycles, motor cycles parts and accessoiries
Updated 14 days ago

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Laboratorios Bago De Bolivia S.A.

BO
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Biotoscana Investments S.A.

UY
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy